William Heisel

MRSA outbreaks among sports teams might be more common than we're led to believe. To get a handle on both health care-associated infections and community-acquired infections, we need to know more about where they originate and what works to fight them.

Not only does the move stand to negatively impact the drug company's bottom line, GSK has broken new ground before in disclosures and remains an outlier.

Add these stories that you might have missed to you reading list.

I wouldn’t blame you if you thought the only thing that happened in the health sphere this year was the implosion of Healthcare.gov. There was some excellent reporting on the problems with the Affordable Care Act, but here are some stories you might have missed.

GlaxoSmithKline, the largest drug company in Britain and one of the largest in the world, has made an industry first move.

It just got even easier to see whether your hospital has a significant infection problem. If state and federal agencies were racing to provide the most useful information in the simplest to understand format, Hospital Compare just took the lead.

Online maps make cool tools, but do they foster cleaner, safer health care? The public knowledge and peer pressure they create can be powerful forces to get hospitals addressing their infection problems.

Wish you had a place to compare hospital post-op infection rates before you consider where to have your procedure? In California you can with the state's map of central-line-associated bloodstream infections (CLABSI), MRSA and VRE.

Liz Szabo's USA Today story -- Doctor accused of selling false hope to families -- is one of the best medical investigations I have read. Here are a few lessons from the piece.

One medical device company offers a warranty for its partial knee product, saying they’ll replace it at any point for the rest of your life. But the company won’t pay for anything but the device itself.